徐作军;
XU Zuo-jun;Department of Respiratory Medicine,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院呼吸内科

摘要(Abstract)：

特发性间质性肺炎(idiopathic interstitial pneumonia,IIP)是一组原因不明的弥漫性实质性肺疾病,主要累及肺间质。随着对IIP研究的不断深入,IIP相关分类和治疗方案也经历了不断演变的过程。本文系统回顾IIP分类变迁、特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)急性加重概念演变以及不同时期IPF治疗方案出台的背景和最新进展,并对今后IIP的分类、诊断和治疗前景进行展望。
Idiopathic interstitial pneumonias( ⅡPs) are a group of heterogeneous diffuse parenchymal lung diseases of unknown etiology,which mainly involve the interstitium of the lung. With the deepening of research,the classification and treatment of ⅡPs have gone through a process of continuous evolution.This article reviewed the changes in the classification of ⅡPs,the evolution of the concept and definition of acute exacerbation of idiopathic pulmonary fibrosis,and the background and latest progress in the treatment plan at different periods of IPF. We also prospected the classification,diagnosis,and treatment of ⅡPs in the future.

关键词(KeyWords)： 特发性间质性肺炎;分类;特发性肺纤维化,急性加重;治疗
idiopathic interstitial pneumonias;classification;idiopathic pulmonary fibrosis,acute exacerbation;treatment

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划“精准医学研究”重点专项(2016YFC0905700)

作者(Authors): 徐作军;
XU Zuo-jun;Department of Respiratory Medicine,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

参考文献(References)：

• [1]Liebow AA,Carrington CB.The interstitial pneumonias[M]//Simon M,Potchen EJ,Lemay E.Frontiers of pulmonary radiology.New York:Grune and Stratton,1969:102-141.
• [2]Katzenstein AL,Myers JL.Idiopathic pulmonary fibrosis:clinical relevance of pathologic classification[J].Am JRespir Crit Care Med,1998,157:1301-1315.
• [3]ATS/ERS.American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias[J].Am JRespir Crit Care Med,2002,165:277-304.
• [4]Travis WD,Costabel U,Hansell DM,et al.An Official American Thoracic Society/European Respiratory Society Statement:Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias[J].Am JRespir Crit Care Med,2013,188:733-748.
• [5]Atkins CP,Loke YK,Wilson AM.Outcomes in idiopathic pulmonary fibrosis:a meta-analysis from placebo controlled trials[J].Respir Med,2014,108:376-387.
• [6]Kondoh Y,Taniguchi H,Kawabata Y,et al.Acute exacerbation in idiopathic pulmonary fibrosis:analysis of clinical and pathologic findings in three cases[J].Chest,1993,103:1808-1812.
• [7]Collard HR,Moore BB,Flaherty KR,et al.Acute exacerbation of idiopathic pulmonary fibrosis[J].Am J Respir Crit Care Med,2007,176:636-643.
• [8]Raghu G,Collard HR,Egan JJ,et al.An official ATS/ERS/JRS/ALAT statement:idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management[J].Am J Respir Crit Care Med,2011,183:788-824.
• [9]Collard HR,Ryerson CJ,Corte TJ,et al.Acute exacerbation of idiopathic pulmonary fibrosis:an international working group report[J].Am J Respir Crit Care Med,2016,194:265-275.
• [10]ATS/ERS.Idiopathic pulmonary fibrosis:diagnosis and treatment international consensus statement[J].Am J Respir Crit Care Med,2000,161:646-664.
• [11]Raghu G,Rochwerg B,Zhang Y,et al.An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline:Treatment of Idiopathic Pulmonary Fibrosis.An Update of the 2011 Clinical Practice Guideline[J].Am J Respir Crit Care Med,2015,192:e3-e19.
• [12]Collard HR,Ryerson CJ,Corte TJ,et al.Acute exacerbation of idiopathic pulmonary fibrosis:an international working group report[J].Am J Respir Crit Care Med,2016,194:265-275.
• [13]Ravaglia C,Bonifazi M,Wells AU,et al.Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases:A comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature[J].Respiration,2016,91:215-227.